Four things to know:
1. The companies said that the initial list price for the two drugs will be 15 percent lower than the price of their reference product.
2. Amgen launched Mvasi, a biosimilar to Avastin. It will be available at a wholesale cost of $677.4 per 100 milligrams and $2,709.60 for a single-dose vial.
3. Allergan has launched Kanjiti, a biosimilar to Herceptin. It will be available at $3,697.26 per 420-milligram vial.
4. Herceptin and Avastin together brought in sales of $5.8 billion in 2018 for Roche.
Read the full report here.
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
Publix Pharmacy to deliver prescriptions to patients before hospital discharge
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
